Novocure Limited (NVCR) CEO Asaf Danziger on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha]
NovoCure Limited - Ordinary Shares (NVCR)
Last novocure limited - ordinary shares earnings: 4/30 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
novocure.com/investor-relations
Company Research
Source: Seeking Alpha
Novocure Limited (NVCR) CEO Asaf Danziger on Q1 2019 Results - Earnings Call Transcript Start Time: 08:00 End Time: 08:40 November 1, 0000 ET Q1 2019 Earnings Conference Call May 02, 2019, 08:00 AM ET Company Participants Bill Doyle - Executive Chairman Asaf Danziger - CEO Wilco Groenhuysen - CFO Ely Benaim - CMO Ashley Cordova - SVP, Finance and IR Conference Call Participants Vijay Kumar - Evercore Arun Jain - JPMorgan Larry Biegelsen - Wells Fargo Greg Fraser - SunTrust Difei Yang - Mizuho Securities Operator Good day, ladies and gentlemen, and welcome to the Novocure First Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we’ll conduct a question-and-answer session and instructions will be given at that time. [Operator Instructions]. As a reminder, this call is being recorded. It is now my pleasure to introduce Senior Vice President of Finance and Investor Relations, Ms. Ashley Cordova. Good morning, everyone, and thank you fo
Show less
Read more
Impact Snapshot
Event Time:
NVCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVCR alerts
High impacting NovoCure Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NVCR
News
- NovoCure Limited (NASDAQ: NVCR) had its "neutral" rating re-affirmed by analysts at Wedbush. They now have a $21.00 price target on the stock.MarketBeat
- NovoCure Limited (NASDAQ: NVCR) had its price target raised by analysts at HC Wainwright from $22.00 to $24.00. They now have a "neutral" rating on the stock.MarketBeat
- METIS Phase 3 Clinical Trial Met Primary Endpoint, Demonstrating a Statistically Significant Extension in Time to Intracranial Progression for Patients with Brain Metastases from Non-Small Cell Lung CancerBusiness Wire
- NovoCure Limited (NASDAQ: NVCR) had its price target raised by analysts at JPMorgan Chase & Co. from $15.00 to $17.00. They now have a "neutral" rating on the stock.MarketBeat
- Does NovoCure (NVCR) Have the Potential to Rally 63.51% as Wall Street Analysts Expect? [Yahoo! Finance]Yahoo! Finance
NVCR
Earnings
- 2/22/24 - Beat
NVCR
Sec Filings
- 3/27/24 - Form 8-K
- 3/5/24 - Form 4
- 3/5/24 - Form 4
- NVCR's page on the SEC website